Statement of Changes in Beneficial Ownership (4)

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden
hours per response...

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Boratto Eva C	2. Issuer Name and Ticker or Trading Symbol CVS HEALTH Corp [ CVS ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) EVP & CFO
(Last)          (First)          (Middle) ONE CVS DRIVE	3. Date of Earliest Transaction (MM/DD/YYYY) 4/1/2020
(Street) WOONSOCKET, RI 02895 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	4/1/2020		F		887 (1)	D	$58.34	69520.5255	D
Common Stock (restricted)								5915	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$58.61 (2)	4/1/2020		A		168956		4/1/2021 (3)	4/1/2030	Common Stock	168956	$58.61	168956	D
Stock Option	$74.29							4/1/2015 (4)	4/1/2021	Common Stock	18882		18882	D
Stock Option	$102.26							4/1/2016 (5)	4/1/2022	Common Stock	27392		27392	D
Stock Option	$104.82							4/1/2017 (6)	4/1/2023	Common Stock	21509		21509	D
Stock Option	$78.05							4/3/2018 (7)	4/3/2024	Common Stock	35062		35062	D
Stock Option	$62.21							4/1/2019 (8)	4/1/2025	Common Stock	35030		35030	D
Stock Option	$54.19							4/1/2020 (9)	4/1/2029	Common Stock	202007		202007	D

Explanation of Responses:
(1)	Surrrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.
(2)	The number of shares subject to the option were calculated using a 30-day average price.
(3)	Option becomes exercisable in four equal annual installments, commencing 4/1/2021.
(4)	Option became exercisable in four equal annual installments, commencing 4/1/2015.
(5)	Option became exercisable in four equal annual installments, commencing 4/1/2016.
(6)	Option becomes exercisable in four equal annual installments, commencing 4/1/2017.
(7)	Option became exercisable in four equal annual installments, commencing 4/3/2018.
(8)	Option became exercisable in four equal annual installments, commencing 4/1/2019.
(9)	Option became exercisable in four equal annual installments, commencing 4/1/2020.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Boratto Eva C ONE CVS DRIVE WOONSOCKET, RI 02895			EVP & CFO

Signatures
/s/ Eva C. Boratto		4/3/2020
**Signature of Reporting Person		Date